118 related articles for article (PubMed ID: 27033953)
1. Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4.
Lin PL; Chang JT; Wu DW; Huang CC; Lee H
Free Radic Biol Med; 2016 Jun; 95():121-32. PubMed ID: 27033953
[TBL] [Abstract][Full Text] [Related]
2. PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2.
Cheng YM; Lin PL; Wu DW; Wang L; Huang CC; Lee H
Oncotarget; 2018 May; 9(41):26342-26352. PubMed ID: 29899863
[TBL] [Abstract][Full Text] [Related]
3. Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses.
Biswas C; Shah N; Muthu M; La P; Fernando AP; Sengupta S; Yang G; Dennery PA
J Biol Chem; 2014 Sep; 289(39):26882-26894. PubMed ID: 25107906
[TBL] [Abstract][Full Text] [Related]
4. DDX3 enhances oncogenic KRAS‑induced tumor invasion in colorectal cancer via the β‑catenin/ZEB1 axis.
Wu DW; Lin PL; Cheng YW; Huang CC; Wang L; Lee H
Oncotarget; 2016 Apr; 7(16):22687-99. PubMed ID: 27007150
[TBL] [Abstract][Full Text] [Related]
5. Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer.
Tong YH; Zhang B; Yan YY; Fan Y; Yu JW; Kong SS; Zhang D; Fang L; Su D; Lin NM
Oncotarget; 2017 Jul; 8(28):45750-45758. PubMed ID: 28501854
[TBL] [Abstract][Full Text] [Related]
6. RV-59 suppresses cytoplasmic Nrf2-mediated 5-fluorouracil resistance and tumor growth in colorectal cancer.
Shen CJ; Lin PL; Lin HC; Cheng YW; Huang HS; Lee H
Am J Cancer Res; 2019; 9(12):2789-2796. PubMed ID: 31911862
[TBL] [Abstract][Full Text] [Related]
7. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).
Arlt A; Bauer I; Schafmayer C; Tepel J; Müerköster SS; Brosch M; Röder C; Kalthoff H; Hampe J; Moyer MP; Fölsch UR; Schäfer H
Oncogene; 2009 Nov; 28(45):3983-96. PubMed ID: 19734940
[TBL] [Abstract][Full Text] [Related]
8. [Effect of lipoxin A(4) on lipopolysaccharide-induced oxidant stress in human umbilical vein endothelial cells].
Liu ZJ; Huang YP; Yi P; Pang HY; Gong JM; Huang YJ; Zhou J; Wu P; Ye DY; Hao H
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):848-53. PubMed ID: 21211285
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic, but not nuclear Nrf2 expression, is associated with inferior survival and relapse rate and response to platinum-based chemotherapy in non-small cell lung cancer.
Chen MJ; Lin PL; Wang L; Cheng YM; Chen CY; Lee H
Thorac Cancer; 2020 Jul; 11(7):1904-1910. PubMed ID: 32394538
[TBL] [Abstract][Full Text] [Related]
10. The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors.
Hu R; Chen N; Yao J; Zhao Q; Zhang F; Li ZY; You QD; Guo QL
Anticancer Drugs; 2012 Jul; 23(6):651-8. PubMed ID: 22526619
[TBL] [Abstract][Full Text] [Related]
11. Oroxylin A exerts anti-inflammatory activity on lipopolysaccharide-induced mouse macrophage via Nrf2/ARE activation.
Ye M; Wang Q; Zhang W; Li Z; Wang Y; Hu R
Biochem Cell Biol; 2014 Oct; 92(5):337-48. PubMed ID: 25247252
[TBL] [Abstract][Full Text] [Related]
12. Expression and correlation of NRF2, KEAP1, NQO-1 and HO-1 in advanced squamous cell carcinoma of the larynx and their association with clinicopathologic features.
Li C; Wu H; Wang S; Zhu J
Mol Med Rep; 2016 Dec; 14(6):5171-5179. PubMed ID: 27840932
[TBL] [Abstract][Full Text] [Related]
13. NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors.
Seng S; Avraham HK; Birrane G; Jiang S; Li H; Katz G; Bass CE; Zagozdzon R; Avraham S
Oncogene; 2009 Jan; 28(3):378-89. PubMed ID: 18981988
[TBL] [Abstract][Full Text] [Related]
14. Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling.
Lee HH; Park SA; Almazari I; Kim EH; Na HK; Surh YJ
Arch Biochem Biophys; 2010 Sep; 501(1):142-50. PubMed ID: 20558128
[TBL] [Abstract][Full Text] [Related]
15. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases.
Tertil M; Golda S; Skrzypek K; Florczyk U; Weglarczyk K; Kotlinowski J; Maleszewska M; Czauderna S; Pichon C; Kieda C; Jozkowicz A; Dulak J
Free Radic Biol Med; 2015 Dec; 89():147-57. PubMed ID: 26393425
[TBL] [Abstract][Full Text] [Related]
16. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.
Deng X; Rui W; Zhang F; Ding W
Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690
[TBL] [Abstract][Full Text] [Related]
17. Induction of NAD(P)H:quinone oxidoreductase 1 expression by cysteine via Nrf2 activation in human intestinal epithelial LS180 cells.
Satsu H; Chidachi E; Hiura Y; Ogiwara H; Gondo Y; Shimizu M
Amino Acids; 2012 Oct; 43(4):1547-555. PubMed ID: 22302369
[TBL] [Abstract][Full Text] [Related]
18. Glyceollins Modulate Tumor Development and Growth in a Mouse Xenograft Model of Human Colon Cancer in a
Jeong G; Oh J; Kim JS
J Med Food; 2019 May; 22(5):521-528. PubMed ID: 30924710
[TBL] [Abstract][Full Text] [Related]
19. Induction of heme oxygenase-1 (HO-1) and NAD[P]H: quinone oxidoreductase 1 (NQO1) by a phenolic antioxidant, butylated hydroxyanisole (BHA) and its metabolite, tert-butylhydroquinone (tBHQ) in primary-cultured human and rat hepatocytes.
Keum YS; Han YH; Liew C; Kim JH; Xu C; Yuan X; Shakarjian MP; Chong S; Kong AN
Pharm Res; 2006 Nov; 23(11):2586-94. PubMed ID: 17048120
[TBL] [Abstract][Full Text] [Related]
20. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
